Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression

Glioblastoma (GBM) is the most frequent malignant glioma. Treatment of GBM patients is multimodal with maximum surgical resection, followed by concurrent radiation and chemotherapy with the alkylating drug temozolomide (TMZ). The present study aims to identify genes implicated in the acquired resist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Le Calvé, Benjamin, Rynkowski, Michal, Le Mercier, Marie, Bruyère, Céline, Lonez, Caroline, Gras, Thierry, Haibe-Kains, Benjamin, Bontempi, Gianluca, Decaestecker, Christine, Ruysschaert, Jean-Marie, Kiss, Robert, Lefranc, Florence
Format: Artigo
Sprache:Inglês
Veröffentlicht: Neoplasia Press Inc. 2010
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2933693/
https://ncbi.nlm.nih.gov/pubmed/20824049
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge